Please login to the form below

Not currently logged in
Email:
Password:

Lonquex

This page shows the latest Lonquex news and features for those working in and with pharma, biotech and healthcare.

Cuts help Teva raise profits, despite flat sales

Cuts help Teva raise profits, despite flat sales

Teva's specialty medicines business also benefitted from the introduction of biosimilar filgrastim (G-CSF) products Lonquex and Granix, which have captured market share of around 10% in the markets they

Latest news

  • Teva withdraws US filing for cancer biologic Teva withdraws US filing for cancer biologic

    There was better news for Teva's G-CSF portfolio however after it launched its long-acting G-CSF product Lonquex (lipegfilgrastim) on November 4 in Germany, the first EU market

  • Neulasta rival from Teva cleared in EU Neulasta rival from Teva cleared in EU

    Neulasta rival from Teva cleared in EU. Lonquex offers competition to Amgen drug in neutropaenia. ... Lonquex is the first biologic medicine from Teva's branded medicines division to be approved for marketing.

  • EMA backs Pomalidomide Celgene in multiple myeloma EMA backs Pomalidomide Celgene in multiple myeloma

    Elsewhere, there were further recommendations for Teva's (Lonquex) lipegfilgrastim, which was recommended for the reduction in white blood cells of cancer patients on chemotherapy; Bavarian Nordic's smallpox vaccine Imnavex;

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics